Home > Financial Ratios > GLAND PHARMA

GLAND PHARMA
Cash Earnings per Share (CEPS)

    Back to All Ratios
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Cash Earnings per Share (CEPS) History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020
   CEPS(Rs) 56.3380.4666.9855.98

What is the latest Cash Earnings per Share (CEPS) ratio of GLAND PHARMA ?

The latest Cash Earnings per Share (CEPS) ratio of GLAND PHARMA is 56.33 based on Mar2023 Consolidated results.
Year Cash Earnings per Share (CEPS)
Mar202356.33
Mar202280.46
Mar202166.98
Mar202055.98

How is Cash Earnings per Share (CEPS) of GLAND PHARMA Trending?

Years Cash Earnings per Share (CEPS) % Change
Mar2023 56.33
-29.99
Mar2022 80.46
20.13
Mar2021 66.98
19.65
Mar2020 55.98 -

Other Financial Ratios of GLAND PHARMA


Compare Cash Earnings per Share (CEPS) ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹27,732.2 Cr -2.6% -7.3% 26.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹361,916.0 Cr 0.3% -7.5% 53.9% Stock Analytics
CIPLA ₹115,034.0 Cr 1.1% -4.8% 56.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,929.0 Cr 1.6% 1.6% 27.6% Stock Analytics
DIVIS LABORATORIES ₹104,873.0 Cr -1.9% 10.7% 21.4% Stock Analytics
ZYDUS LIFESCIENCES ₹100,322.0 Cr 5.2% -0.2% 90.1% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-2.6%

-7.3%

26.7%

SENSEX

-0.6%

0.3%

21.8%


You may also like the below Video Courses